搜索临床试验以:4SC-202 与 Pembrolizumab 联合使用
总计457个结果
-
Yonsei University撤销
-
Bristol-Myers Squibb撤销
-
National Cancer Institute (NCI)完全的复发性弥漫性大 B 细胞淋巴瘤 | 难治性弥漫性大 B 细胞淋巴瘤 | 复发性高级 B 细胞淋巴瘤 | 难治性高级 B 细胞淋巴瘤 | 复发性转化 B 细胞非霍奇金淋巴瘤 | 难治性转化 B 细胞非霍奇金淋巴瘤美国
-
Celleron Therapeutics Ltd.未知
-
University of UtahRepare Therapeutics招聘中
-
Innovent Biologics (Suzhou) Co. Ltd.WuXi CDS Clinical Research (Shanghai) Co.Ltd.完全的
-
The Second Affiliated Hospital of Chongqing Medical...Chongqing Medical University; First Affiliated Hospital of Chongqing Medical University; Chongqing... 和其他合作者完全的
-
Dayanand Medical College and Hospital完全的
-
Mannkind Corporation完全的
-
Jiangsu Simcere Pharmaceutical Co., Ltd.Shanghai Xianxiang Medical Technology Co., Ltd.招聘中
-
Sidney Kimmel Comprehensive Cancer Center at Johns...Bristol-Myers Squibb主动,不招人
-
Compugen LtdBristol-Myers Squibb主动,不招人
-
AHS Cancer Control AlbertaCelgene主动,不招人
-
Sheba Medical Center未知
-
National University Hospital, Singapore招聘中转移性实体恶性肿瘤 | Advance Solid Malignancies新加坡
-
Peking Union Medical College HospitalJiangsu HengRui Medicine Co., Ltd.尚未招聘
-
Arvinas Estrogen Receptor, Inc.Pfizer主动,不招人
-
Dentsply Sirona Implants and Consumables完全的
-
SanofiHanmi Pharmaceutical Company Limited终止
-
The First Affiliated Hospital of Soochow UniversityThe Second People's Hospital of Huai'an; First Affiliated Hospital Bengbu Medical College; Jining... 和其他合作者招聘中
-
Ming HouPeking Union Medical College Hospital; Cancer Institute and Hospital, Chinese Academy of Medical... 和其他合作者完全的
-
C. Michael DunhamSt. Elizabeth Youngstown Hospital完全的
-
Bio-Path Holdings, Inc.完全的复发性成人急性髓性白血病 | 急性淋巴细胞白血病 | 骨髓增生异常综合症 | Ph1 阳性 CML美国
-
AstraZeneca完全的晚期或转移性乳腺癌 | ER+ve 晚期或转移性乳腺癌加拿大, 法国, 大韩民国, 捷克语, 秘鲁, 英国, 西班牙, 日本, 墨西哥, 新加坡, 保加利亚
-
Indiana UniversityBreast Cancer Research Foundation; Geron Corporation完全的
-
Clinica Universidad de Navarra, Universidad de...Highlight Therapeutics招聘中
-
Latin American Cooperative Oncology GroupMerck Sharp & Dohme LLC主动,不招人
-
The First Affiliated Hospital of Xiamen University招聘中